Jul 14, 2021 / 02:30PM GMT
Ahu Demir - Ladenburg Thalmann & Co. Inc. - Analyst
Hello, everyone. Our next presenting company is Cyclacel Pharmaceuticals. And from the Company we have CEO, Spiro Rombotis. Spiro, thank you so much for joining us today, and it's our great pleasure to host Cyclacel presentation. I'll pass it to you for a presentation, then following up -- I'll follow-up with a Q&A session. Please take it away.
Spiro Rombotis - Cyclacel Pharmaceuticals, Inc. - President & CEO
Thank you, Ahu, and thank you very much to Ladenburg for inviting us to join this year's healthcare conference. I would also like to introduce my colleague, Paul McBarron, our COO and CFO, who joins me today. I will go through a few slides just primarily to remind everybody of our endeavors to bring solutions to patients with unmet medical needs, and then will turn into questions.
First of all, I would like to draw your attention to our usual disclaimer regarding forward-looking statements I'll be making in my presentation and my subsequent remarks, and direct your attention to our
Cyclacel Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot